| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faf522b8b83eded745c73018576219ba |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 |
| filingDate |
2008-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7ad77b0916fc4af67cc9b4e7c7cb4be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9124f136dd3974655f10724d9f37d52f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6227e209d11b674840d3bdf7b24c8f67 |
| publicationDate |
2011-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2011207764-A |
| titleOfInvention |
Inhibition of hepatitis C virus replication by CDK inhibitors |
| abstract |
PROBLEM TO BE SOLVED: To provide a medicament useful for treating a disease associated with hepatitis C virus infection by inhibiting replication of hepatitis C virus. A hepatitis C virus replication inhibitor comprising as an active ingredient a compound having a cdk inhibitory activity or a salt thereof, or a solvate thereof or a hydrate thereof, and hepatitis C comprising the inhibitor as an active ingredient Medicine for the treatment of infectious diseases caused by viruses. Furthermore, a method for treating hepatitis C virus infection using the medicament. [Selection] Figure 5 |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102263843-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160041695-A |
| priorityDate |
2008-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |